Yujing Liang

发表

Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma

D. Dong, H. Mai, Jie Tian, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT

R. Sun, Xiaofei Lv, H. Mai, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study

H. Mai, Qiu-Yan Chen, Chao-chao Du, 2022, European Radiology.

Treatment of nasopharyngeal carcinoma in unique scenarios

H. Mai, Qiu-Yan Chen, Yujing Liang, 2020 .

Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2022, BMC cancer.

Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma

D. Dong, H. Mai, Jie Tian, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Annals of translational medicine.

Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma.

Ying Sun, Jun Ma, H. Mai, 2019, European journal of cancer.

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.

Ying Huang, R. Sun, C. Qian, 2018, The Lancet. Oncology.

Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis

Jun Ma, J. Bei, Chong Zhao, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study

H. Mai, Qiu-Yan Chen, Chao-chao Du, 2022, Advances in radiation oncology.

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer communications.

The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, Journal of Cancer.

Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study

H. Mai, Qiu-Yan Chen, Chao-chao Du, 2022, European Radiology.

Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection

H. Mai, Xiang Guo, Qiu-Yan Chen, 2020, Cancer biology & medicine.

The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, International journal of radiation oncology, biology, physics.

Alpha-fetoprotein–producing recurrent nasopharyngeal carcinoma: A case report

Li-Li Liu, M. Cai, H. Mai, 2021, SAGE open medical case reports.

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Oral oncology.

Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort Study

Jun Ma, H. Mai, M. Hong, 2019, Cancer research and treatment : official journal of Korean Cancer Association.

Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I–II nasopharyngeal carcinoma: a nest case-control study

R. Sun, Xiaofei Lv, H. Mai, 2021, European Radiology.

Optimizing the Treatment Pattern for De Novo Metastatic Nasopharyngeal Carcinoma Patients: A Large-Scale Retrospective Cohort Study

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Frontiers in Oncology.

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, BMC Cancer.

Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Frontiers in Pharmacology.

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial

R. Sun, Qing Liu, Chong Zhao, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Qingmei He, Na Liu, Jun Ma, 2018, Cancer communications.

The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma

Qiu-Yan Chen, Yujing Liang, Yan He, 2018, OncoTargets and therapy.

Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score–matched analysis

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study

R. Sun, C. Qian, Xiang Guo, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020

H. Mai, Qiu-Yan Chen, Yujing Liang, 2022, JAMA network open.

Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.

Jun Ma, J. Shao, J. Bei, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2020, Cancer communications.

The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, International journal of radiation oncology, biology, physics.

Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, European journal of cancer.

Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, BMC Cancer.

Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma

R. Sun, H. Mai, H. Mo, 2021, JAMA network open.

Establishment of a prognostic nomogram to identify optimal candidates for local treatment among patients with local recurrent nasopharyngeal carcinoma.

R. Sun, H. Mai, Qiu-Yan Chen, 2020, Oral oncology.

Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma

H. Mai, H. Mo, Qiu-Yan Chen, 2020, Therapeutic advances in medical oncology.

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level

H. Mai, Qiu-Yan Chen, Yujing Liang, 2020, BMC Cancer.

Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinoma.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, Oral oncology.

Role of zoledronic acid in nasopharyngeal carcinoma patients with bone-only metastasis at diagnosis.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Oral oncology.

The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer management and research.

The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019 .

Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus DNA

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Head & neck.

Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer research and treatment : official journal of Korean Cancer Association.

The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis

Xiao-Dan Lin, H. Mai, Qiu-Yan Chen, 2019, Journal of Cancer.

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer medicine.

Jun Ma, H. Mai, Qiu-Yan Chen, 2019, BMC Cancer.

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.

Ying Huang, R. Sun, Chong Zhao, 2023, The Lancet. Oncology.

A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients.

Jiang Li, R. Sun, J. Xia, 2023, European journal of cancer.

H. Mai, Qiu-Yan Chen, Yujing Liang, 2018, BMC Cancer.

Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [18F]FDG PET/CT parameters

H. Mai, Qiu-Yan Chen, Yujing Liang, 2022, European Radiology.

Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma

Chuan-miao Xie, R. Sun, H. Mai, 2021, BMC Cancer.

Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Drug design, development and therapy.

Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.

R. Sun, Chong Zhao, H. Mai, 2023, European journal of cancer.

Management of Suboptimal Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Re-induction Therapy or Direct to Radiotherapy?

H. Mai, Qiu-Yan Chen, Yujing Liang, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

H. Mai, Qiu-Yan Chen, Yujing Liang, 2019, Cancer medicine.